The forecast for ovary malignant neoplasms mortality in Canada from 2024 to 2028 shows a year-on-year decline, indicating a positive trend. In 2023, the standardised rate was higher than the forecasted values for subsequent years. The yearly decline from 2024 to 2028 ranges from 1.2% to 2.6%, with a notable 2.6% decrease between 2027 and 2028. The five-year compound annual growth rate (CAGR) stands at -1.6% suggesting a consistent reduction in mortality rates over the period.
Future trends to watch for include advancements in early detection, improved treatments, and healthcare access, which may further drive down mortality rates. Monitoring these factors will be crucial to understanding and sustaining the downward trend in ovary cancer mortality.
